Erivedge was given a fast six-month review because there are no approved treatments for advanced basal cell carcinoma. See FDA Announcement here.
“For the FDA to approve a drug with serious side effects within six months, suggests that the Cannabis Science should receive similar consideration when we submit our application for the treatment of basal cell carcinoma,” said Dr. Melamede, CEO, Cannabis Science. Click here for further information on side effects associated with Erivedge.
still looking for the pr I wanted but this is good enough i think
but if it is 60 days that's even better for my freebies
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.